Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dutch reimburse cervical cancer heat therapy:

This article was originally published in Clinica

Executive Summary

The treatment of advanced cervical cancer using deep regional hyperthermia and radiation has been approved for reimbursement in the Netherlands. The Dutch parliament has also confirmed deep hyperthermia as the treatment of first choice for advanced cervical cancer. The move follows the positive outcome of a study on the heat therapy carried out at the University Medical School of Rotterdam. The clinical trial used the BSD-2000 system, developed by US company BSD Medical, to treat deep cervical tumours. Deep regional hyperthermia as an adjunct to cervical cancer treatment is already reimbursed in the German states of Bavaria, Berlin and Baden-Wurttemberg.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel